OR7E109P

Across TCGA pan-cancer cohorts, OR7E109P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of OR7E109P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where OR7E109P RNA is repressed in tumor relative to normal tissue. In most cancer types OR7E109P is over-expressed in tumor, although a few such as KIRC and KIRP show the opposite, repressed pattern.

KIRC, KIRP, and THCA are the cancer types where OR7E109P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR7E109P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	II,III,IV	−0.040	<.001	11	view →
KIRP	Male	All	−0.046	.002	4	view →
THCA	Female	III,IV	−0.057	.010	2	view →
COAD	All	All	+0.028	.027	2	view →
LUSC	All	All	+0.034	.007	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

OR7E109P–KIRC

Open the KIRC breakdown →